Intellipharmaceutics (IPCI) Forum
Sign up Calendar Latest Topics
 
 
 


Reply
  Author   Comment   Page 1 of 3      1   2   3   Next
wimuskyfisherman

Moderator
Registered:
Posts: 553
Reply with quote  #1 
So what does IPCI do with an approval for Effexor? Do they have any plans to market this in the US? Or is it similar Keppra and Gluco? Maybe we get a PR about the approval with a sidenote that they have an unnamed partner for Effexor in Vietnam, Philipines and Malaysia... And that they cannot disclose the financial details on it either. Come on Odidi... Show me I am wrong... Announce a US partner for Effexor...        

Effexor is pretty much a worthless approval for shareholders. Unless Odidi can partner it in US... But it is not a worthless approval for Odidi, as he and his wife probably get a big bonus... How just is that... He just screwed all long term shareholders, then a worthless approval comes along and that prick will take a bonus like he did a good job. No bonus should be paid. Odidi should have to answer why it took way to long for this approval and it is now virtually worthless...        
0
wimuskyfisherman

Moderator
Registered:
Posts: 553
Reply with quote  #2 
Pharmer - I hope you are right. But the orange book lists 11 other companies that beat ipci to the effexor xr party. So I am not holding my breath on a partnership. Especially one with an upfront payment. But maybe they can find an unnamed distributor in Tibet...
0
Samsa1

Moderator
Registered:
Posts: 692
Reply with quote  #3 
Pharmer, you really were not talking about effexor when you stated
Quote:
My guess is about $10 -$29 MILLION in money with the PARTNERSHIP that is including milestone payments AND THIS TIME CERTAIN PEOPLE are having a SAY INTO THE PARTNERSHIP and the AMOUNT of cash into the Deal okay


I assume you were talking about a deal for Rexista here?   Effexor, as Wim pointed out already has numerous other companies that beat us to the punch.  without a strong partner, all I see is this costing us another 2 million in bonuses and it sitting collecting dust like Keppra and glucho.   now for Rexista I could see those types of payments.  10 to 20 million up front. 

As for me getting out. you really are kidding aren't you?   if I ever saw $10 a share, I would consider myself the luckiest person on earth!   Only losing my initial 50k.  I kick myself every damn time I think about it that I got back in.  I got sucked back in thinking if Boyd was investing that much at $1.10 I could buy back at 95 cents and sell around $1.15 and at least recover a little of what I lost.  and look what happened!  it has been down ever since to our current $0.05 cents!   Thats 300,000 shares from $0.95 down to $0.05!   or now only 30,000 shares from $9.50 down to $0.53 cents!   Either way you want to looks at it! 

And now we find out the FDA approved this on Friday and still no PR yet they must meet compliance by tomorrow?  If you feel this will pop us anywhere, then they are complete idiots for not releasing today before hours!  But let us get another delisting notice.   priceless.   actually no I can put a price tag on it.   $300,000 for me!
0
AmigoMike

Senior Member
Registered:
Posts: 120
Reply with quote  #4 
Only way IPCI sees $10 million-$29 million is an outright sale and even then ..... doubt it. Maybe cumulative over 5 years or so.

But there are already 11 companies on Venlafaxine XR including some of the big boys in generics. First generics were 8 years ago ..... so IPCI is a day late and a dollar short on the potential for this to generate any signficant money. As has already been proven, having a partner for the generics doesn’t work cause the margins are always eroding. See Seroquel XR.

And the “news” IPCI is pumping out so far is worthless drivel. No real value to it as can be seen by the lack of price movement and literally zero information.

Of interest today was to see 12 million shares trade when there are roughly 8+ million presently outstanding and even fewer that are in the float trading. And the stock really didnt do much.

Amigo Mike
0
AmigoMike

Senior Member
Registered:
Posts: 120
Reply with quote  #5 
Will be fun to see the approval letter for venlafaxine XR when its posted. Last approval I believe was in 2017 (McLeod) for an ANDA filed in 2013 I think, Let’s see how many CRLs IPCI got. The 2017 approval had 1 CRL in 2016. How many did IPCI get ???

IPCI filed in May 2010 LOL.

Amigo Mike
0
wimuskyfisherman

Moderator
Registered:
Posts: 553
Reply with quote  #6 
Pharmer and all- Looks like NASDAQ notice has come. What is ridiculous is that Odidi could not figure a way to keep NASDAQ listing. He did a 10-1 RS and then a toxic offering- which he alluded was to meet the shareholder equity requirement. However, that toxic offering made it impossible for IPCI to ever hit a PPS of $1 again without another RS... So it looks to me like Odidi did that toxic offering to keep the doors open and pay his and his wife's salary for another year. And what is even sadder, is this new approval will  likely trigger a large bonus for the Odidi's and others at IPCI. So in the end, shareholders get the shaft because IPCI is a train wreck managed by worthless idiots... And those idiots are about to get a large bonus for a worthless approval that should have been secured 5 F***ING YEARS AGO.
0
AmigoMike

Senior Member
Registered:
Posts: 120
Reply with quote  #7 
Yeah .... PR at 8pm. LOL. First smart thing MGMT has done in a while. Now drop news on Effexor in the AM .... but no grace period for IPCI this time from the NASDAQ. Company will have to beg again.

Amigo Mike
0
fabioulous

Member
Registered:
Posts: 69
Reply with quote  #8 
Amigo, pls let me know once you find out about the CRLs IPCI received before getting the final approval.
I cannot understand how a CRL cannot be considered material information for the shareholders, so that the management can decide whether discolosing it or not. I would say it is something for a legal suit...but just curious to know how good they are at filing ANDAs.

The only slight positive I see here is that the fact they got approved means they are not a pure and simple con artists. They are more like in between thiefs and incompetent.

For what it regards to NASDAQ listing: the idiot in chief last time asked for an extension with a no clue deadline, just the reinforce the idiocy sorrounding his person.

now the only solution I see is another R/S, because I don't buy it NASDAQ is giving them a further extension.

Finally, Pharmer: yes, IPCI is putting out a number of PRs, but with no effect on the price. Like to say... either Odidi speaks or shuts up...it doesn't matter. He has no credibility left ...if he tries to sit at a table for playing cards he would be banned .
0
Samsa1

Moderator
Registered:
Posts: 692
Reply with quote  #9 
well as I figured.   You are correct Pharmer.  The company is putting out regular PR's.  This time the delisting notice! amazing how they could not PR an approval but they PR this?  Pharmer, you say this is only chapter 7 and 5 more to go.  Are you referring to Bankruptcy?????   LOL   Because it sure looks that way.
0
wimuskyfisherman

Moderator
Registered:
Posts: 553
Reply with quote  #10 
Pharmer- Great they have another prototype drug they can't afford to develop and there are no partners that want to pay for the studies. Just like Regabatin... How far has Regabatin come since they filed the IND?
0
Samsa1

Moderator
Registered:
Posts: 692
Reply with quote  #11 
Pharmer, does this mean you no longer feel I have a chance or even a breath of breaking even?  if you now are saying
Quote:
I am NOT SELLING IT ALL perhaps 50% of the shares if it hits a certain price range and hold the remaining 50% for well a POP POP POP ABOVE $1.00 AND AFTER SELL 25% AND JUST BANK THE OTHER 25% FOR DOWN THE ROAD SAY 1-3 YEARS


I was hoping we would see that pop on news of refiling and Hap studies and possibly a partnership for Rexista.  now who knows. I must agree the company has been pumping out PR's but to what effect?  the only one that seemed to have any effect is the negative one!  as always.  You may hold more shares of IPCI than any other company.  I am sure you have a way to protect yourself and probably was part of the offering.  Me, I did that and look at where I am!  I bought and bought and bought continually averaging down. until I could no longer afford to lose more money. 

I recall you saying before when the price was around 60 cents (pre-split) that we should load up at these crazy low levels.  Well that is now equal to $6.  I think you forgot to tell us the rest of the equation, which was if the price goes up a penny sell because its going to fall like a rock form here one out!   I have no doubt you will make out well. I hope you understand why I can not hold the same excitement as you do.  I hold more in this stock than any other stock I ever did and lost it all.  so forgive me if my perception of IPCI is not as rosy.
0
wimuskyfisherman

Moderator
Registered:
Posts: 553
Reply with quote  #12 
The only way this ever goes above 75 cents again is another reverse split.
0
Samsa1

Moderator
Registered:
Posts: 692
Reply with quote  #13 
wim, honestly, That is what I am afraid of.   I noticed we keep getting lower highs and lower lows.   we are still being traded down.  we now got delisting notice.  They are constantly putting out PR's and none get the price up and stay up, yet 1 negative PR on known or expected news and we are ran down.  I suspect we continue to get walked down forcing another Reverse Split OR they just run us down knowing he can't do a RS without shareholder approval and we get delisted.  which that news will drive us down to a penny or 10 cents post split price.    Lets face it, at the current float of around 8 million shares he needs to get to $5 or $6 range just to get Market cap.  Now honestly, any other company with 5 approved drugs and an NDA refiled and ready for adcom should be trading at around 40 million market cap.  But we both know the manipulation in this stock wont allow that to happen.  
0
AmigoMike

Senior Member
Registered:
Posts: 120
Reply with quote  #14 
Samsa,

It amazes me that you still keep repeating the valuation arguments for IPCI that you made over last couple years.

THIS ISNT ANY OTHER COMPANY. IT CANNOT MARKET ITS OWN APPROVED DRUGS. SO FAR ITS JUST GENERICS ALL OF WHICH ARE SO LATE TO THE GAME THEY DONT HOLD ANY REAL SIGNIFICANT VALUE.

I don't understand. You still don't seem to get it. The failure of Seroquel should drive the point home for you.

As I have said for YEARS, I originally bought for PODRAS and it's potential to be licensed out for multiple candidates. But Odidi has done literally nothing with it for years.

Lastly, you all need to take it easy on the pumpers. Granted they sling alot of bull .... But you need them to help boost the price. My Ihub post about this was deleted by the newest pumper. Love those folks that post 300 times a day like they know stuff and have done their DD. Just the Ihub pumping network that smells opportunity to make a quick buck on a penny stock. It's actually a waste of time to read and if you dispute their "facts" they just spew the same drivel over and over. I like to use the ignore button in these cases. No time to read the same messages that offer nothing 50 times a day. 

As the saying goes ..... "empty barrels make the most noise"

Amigo Mike
0
fabioulous

Member
Registered:
Posts: 69
Reply with quote  #15 
Amigo, is there a way to know how many CRLs did they got for Effexor ?

What's your idea about the delisting? is there a viable wayout ?

Many thanks
0
Previous Topic | Next Topic
Print
Reply

Quick Navigation:

Easily create a Forum Website with Website Toolbox.